Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/DIMENSION-THERAPEUTICS-IN-24543265/news/Dimension-Announces-Interim-Topline-Results-from-Ongoing-Phase-1-2-Clinical-Program-for-DTX101-Dime-23786373/?utm_source=whatsapp&utm_medium=social&utm_campaign=share